Shares of Tesla (NASDAQ:TSLA) have tumbled more than 57% over the past four weeks. The selloff, which comes amid a broader stock market plunge, prompted BofA Securities to upgrade the name to 'Neutral' from 'Underperform' with a $500 price target. BofA's
The analyst upgraded the e-commerce stock to buy from neutral and raised his price target to $82 per share from $78. BofA ’ s forecast implies nearly 28% upside from Monday ’ s $64.21 close. "Revenue growth and disciplined spending point to healthy margin expansion going forward. We for...
BofA analyst Joshua Dennerlein initiated coverage of Lineage (LINE) with a Buy rating and $100 price target. As the world’s largest and second publicly-traded REIT solely focused on owning, acquiring, and operating cold storage warehouses, the firm thinks the biggest advantage that Lineage has...
My AccountGet Benzinga Pro Data & APIs Events Marketfy Premarket Boost Advertise Contribute LoginRegister Our Services News Markets Options Ratings Ideas Money Crypto Cannabis Research My Stocks Tools
Meanwhile, Evercore ISI increased its price target for Bank of America shares, buoyed by investor optimism regarding the bank's net interest income expansion prospects for 2025. The bank's management has indicated expectations for net interest income growth, driven by modest increases in loans and ...
The analyst cites valuation for his “Neutral” to “Underperform” downgrade following the stock’s recent run. According to Murphy, who also reduced TSLA’s price target to $485 from $500, the electric carmaker faces several hurdles, including ongoing/future production challenges, a burnout patt...
BofA initiated coverage of Globant with a Neutral rating and $202 price target. Globant has navigated the current downturn in discretionary spending “well relative to comps,” but the firm believes this is already reflected in the stock’s elevated valuation and year-to-date share price outperfor...
is among the cheapest of its big bank peers and raised his target price on the stock by $4.50 to $16.50. Oppenheimer analyst Carl McDonald said that the largest U.S. health insurer UnitedHealth Group Inc. faces a smaller profit in 2010 because it expects unrealistic Medicare reimbursement ...
ESG Refinitiv B-More Ratings Analysts' Consensus Sell Buy Mean consensus OUTPERFORM Number of Analysts 26 Last Close Price 230.40USD Average target price 236.09USD Spread / Average Target +2.47%Consensus Profit revisions Estimate revisions Quarterly ...
BofA increased Nvidia's full year 2025 EPS estimate to $2.87 from $2.81; the 2026 estimate to $4.47 from $3.90; and 2027 to $5.67 from $4.72. The investment firm also reiterated its Buy rating and increased its price target on the stock to $190 from $165.Nvidiashares have flirted wit...